CARES: Support for young women taking PrEP
Part of Infections clinical trials.
This study tests a program to help young women and girls stick with their HIV prevention medication (PrEP). It explores whether extra support can make it easier to stay on PrEP and protect against HIV.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a young woman or girl between 16 and 24 years old.
- You started taking PrEP (as a pill, ring, injection, or implant) within the last 6 months (or 3 months for some types).
- You are willing to let the study team see your medical records.
- You speak English, isiXhosa, Shona, or Ndebele.
- Your next PrEP refill is due within the next month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps connect young people aged 13–24 to PrEP, a daily pill that prevents HIV. It tests whether offering PrEP in clinics or community locations makes it easier for you to get and stay on this prevention medication.
This study tests a program called PrEP Choice to help young people learn about and start PrEP, a daily pill that prevents HIV. It aims to see if offering choices in PrEP care makes it easier to use.
This study offers different forms of HIV prevention medicine (PrEP) to young women ages 18–30 who are visiting clinics for reproductive health services like family planning or postnatal care. It aims to see which delivery method works best for you.
This study offers a way for adolescent girls and young women in Tanzania to get PrEP (a daily pill that helps prevent HIV) from local pharmacies instead of only from clinics. It aims to make starting and staying on PrEP easier and more convenient.
This study tests a program to help women at risk for HIV get PrEP, a medicine that prevents HIV. It focuses on women who may want to have a child or have been pregnant recently.
This study tests a program to help adolescent girls and young women at high risk of HIV take PrEP consistently. It aims to improve access and adherence to PrEP, a daily pill that prevents HIV.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.